JAMONY
Jacob Asset Management of New York’s DiaMedica Therapeutics DMAC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | $435K | Sell |
168,730
-30,000
| -15% | -$77.4K | 0.61% | 45 |
|
2023
Q2 | $859K | Sell |
198,730
-35,000
| -15% | -$151K | 0.97% | 38 |
|
2023
Q1 | $358K | Hold |
233,730
| – | – | 0.42% | 49 |
|
2022
Q4 | $369K | Sell |
233,730
-4,770
| -2% | -$7.54K | 0.45% | 49 |
|
2022
Q3 | $296K | Hold |
238,500
| – | – | 0.32% | 50 |
|
2022
Q2 | $482K | Sell |
238,500
-26,500
| -10% | -$53.6K | 0.49% | 45 |
|
2022
Q1 | $663K | Sell |
265,000
-10,000
| -4% | -$25K | 0.4% | 50 |
|
2021
Q4 | $1.03M | Hold |
275,000
| – | – | 0.46% | 49 |
|
2021
Q3 | $1.1M | Hold |
275,000
| – | – | 0.4% | 52 |
|
2021
Q2 | $1.22M | Buy |
275,000
+90,000
| +49% | +$401K | 0.4% | 56 |
|
2021
Q1 | $1.69M | Buy |
185,000
+45,000
| +32% | +$412K | 0.66% | 43 |
|
2020
Q4 | $1.42M | Buy |
+140,000
| New | +$1.42M | 1.07% | 29 |
|